14-day Premium Trial Subscription Sign Up For FreeGet Free

Champions Oncology Stock Forecast NASDAQ:CSBR

Price Target and Analyst Ratings

Most Recent Rating

On August 03, 2021 "Roth Capital" gave "" rating for CSBR. The price target was set to $10.62+1.1%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-03 Reiterated by Roth Capital $10.62 $10.62+1.1%
2021-03-22 Buy Target Raised by Roth Capital $11.79 $13.50 → $16.00
2021-03-15 Buy Target Raised by Roth Capital $13.71 $13.50 → $16.00

CSBR Stock Trend

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 11.69% during the next 3 months and, with a 90% probability hold a price between $10.72 and $12.41 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-20 $9.61 $10.37 $11.13
2021-09-21 $9.63 $10.39 $11.14
2021-09-22 $9.65 $10.41 $11.16
2021-09-23 $9.67 $10.42 $11.18
2021-09-24 $9.69 $10.44 $11.20
2021-09-27 $9.70 $10.46 $11.22
2021-09-28 $9.72 $10.48 $11.24
2021-09-29 $9.74 $10.50 $11.26
2021-09-30 $9.76 $10.52 $11.27
2021-10-01 $9.78 $10.54 $11.29
2021-10-04 $9.80 $10.55 $11.31
2021-10-05 $9.82 $10.57 $11.33
2021-10-06 $9.83 $10.59 $11.35
2021-10-07 $9.85 $10.61 $11.37
2021-10-08 $9.87 $10.63 $11.38
2021-10-11 $9.89 $10.65 $11.40
2021-10-12 $9.91 $10.66 $11.42
2021-10-13 $9.93 $10.68 $11.44
2021-10-14 $9.94 $10.70 $11.46
2021-10-15 $9.96 $10.72 $11.48
2021-10-18 $9.98 $10.74 $11.50
2021-10-19 $10.00 $10.76 $11.51
2021-10-20 $10.02 $10.78 $11.53
2021-10-21 $10.04 $10.79 $11.55
2021-10-22 $10.06 $10.81 $11.57
2021-10-25 $10.07 $10.83 $11.59
2021-10-26 $10.09 $10.85 $11.61
2021-10-27 $10.11 $10.87 $11.62
2021-10-28 $10.13 $10.89 $11.64
2021-10-29 $10.15 $10.90 $11.66

About Champions Oncology

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing per... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT